| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.12B | +64.7% |
| Cost of Revenue | $73.0M | -64.0% |
| R&D Expense | $342.3M | -12.5% |
| SG&A Expense | $157.5M | -53.3% |
| Operating Income | $452.8M | +281.9% |
| Interest Expense | $11.5M | +10.5% |
| Pre-tax Income | $442.2M | +350.4% |
| Income Tax | $1.9M | -82.9% |
| Net Income | $440.3M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $240.6M | -54.6% |
| Short-term Investments | $494.4M | +25.9% |
| Inventory | $11.5M | +32.0% |
| Current Assets | $978.3M | -13.3% |
| Total Assets | $1.18B | -24.6% |
| Current Liabilities | $459.9M | -60.2% |
| Total Liabilities | $1.30B | -40.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$244.6M | -180.3% |
| Capital Expenditures | $5.6M | -57.4% |
| Investing Cash Flow | -$78.3M | +61.6% |
| Financing Cash Flow | $27.7M | -89.4% |
| Free Cash Flow | -$250.2M | -149.4% |
| +334.8% |
| EPS (Basic) | $2.72 | +321.1% |
| EPS (Diluted) | $2.58 | +309.8% |
| Stockholders' Equity |
| -$127.8M |
| +79.5% |